Since the liver receives almost 25% of the total cardiac output, it is sensitive to hemodynamic alterations.[17] Therefore, liver dysfunction (i.e., elevated serum transferase levels) is commonly seen in patients with CVD.[18] It is reasonable to speculate that the AST/ALT ratio might be a prognostic marker of CVD patients. The gene discussed is GPT; the disease is Decreased liver function.